Total Return Price Chart

Historical Total Return Price Data

View and export this data back to 1995. Start Trial.
Date Value
October 13, 2026 12.82
October 12, 2026 12.66
October 09, 2026 12.75
October 08, 2026 11.01
October 07, 2026 11.22
October 06, 2026 11.32
October 05, 2026 12.56
October 02, 2026 10.46
October 01, 2026 10.60
September 30, 2026 10.81
September 29, 2026 10.82
September 28, 2026 10.80
September 25, 2026 10.63
September 24, 2026 10.60
September 23, 2026 10.55
September 22, 2026 10.83
September 21, 2026 10.41
September 18, 2026 10.11
September 17, 2026 10.00
September 16, 2026 9.35
September 15, 2026 9.23
September 14, 2026 9.59
September 11, 2026 9.42
September 10, 2026 9.30
September 09, 2026 9.85
Date Value
September 08, 2026 10.19
September 04, 2026 10.22
September 03, 2026 10.34
September 02, 2026 10.32
September 01, 2026 10.12
August 31, 2026 9.37
August 28, 2026 9.26
August 27, 2026 9.05
August 26, 2026 9.21
August 25, 2026 9.44
August 24, 2026 8.86
August 21, 2026 8.94
August 20, 2026 8.42
August 19, 2026 8.79
August 18, 2026 7.93
August 17, 2026 8.07
August 14, 2026 8.05
August 13, 2026 8.14
August 12, 2026 7.96
August 11, 2026 7.95
August 10, 2026 7.89
August 07, 2026 7.95
August 06, 2026 7.74
August 05, 2026 7.70
August 04, 2026 7.66

Total Return Price Definition

The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.

Read full definition.

Total Return Price Range, Past 5 Years

View Total Return Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Price Benchmarks

View Total Return Price Benchmarks
Start Trial
Moderna, Inc. 216.25
Merck & Co., Inc. 141.98
Pfizer Inc. 28.37
Agenus, Inc. 6.95
Editas Medicine, Inc. 2.445